[开放获取]   海姆泊芬光动力疗法治疗鲜红斑痣专家共识（2024）

doi:10.35541/cjd.20230584

Abstract

Abstract: 【Abstract】 Port-wine stain（PWS）is a congenital and progressive capillary malformation characterized by structural abnormalities of intradermal capillaries and postcapillary venules. The visible skin manifestations on the face and neck are often considered a disfigurement, and the accompanying social stigma often causes serious emotional and physical impact. As a new treatment for PWS, photodynamic therapy（PDT） mediated by hemoporfin, also known as hematoporphyrin monomethyl ether（HMME）, has shown good safety and efficacy, and is one of the most promising strategies for the treatment of PWS. Since 2017, HMME-PDT has been widely used for the treatment of PWS. To further standardize the clinical application of HMME-PDT, experts in the consensus group developed this consensus based on the latest research achievements and extensive discussions, so as to provide guidance for clinicians.

Key words: Port-wine stain, Hematoporphyrin photoradiation, Hematoporphyrin monomethyl ether-mediated photodynamic therapy, Therapy, Expert consensus

The Consensus Development Expert Group of Hematoporphyrin Monomethyl Ether-mediated Photodynamic Therapy for Treating Port-wine Stains. Expert consensus on hematoporphyrin monomethyl ether-mediated photodynamic therapy for treating port-wine stains （2024）[J]. Chinese Journal of Dermatology, 2024, 57(7): 581-589.doi:10.35541/cjd.20230584

References ［58］

［1］	Yu L, Qin K, Deng X, et al. Epidemiological study of capillary malformation among 7299 infants under 1 year of age in China［J］. J Eur Acad Dermatol Venereol, 2023,37（3）:627⁃632. doi: 10.1111/jdv.18767.
［2］	Hershkovitz D, Bercovich D, Sprecher E, et al. RASA1 mutations may cause hereditary capillary malformations without arteriovenous malformations［J］. Br J Dermatol, 2008,158（5）:1035⁃1040. doi: 10.1111/j.1365⁃2133.2008.08493.x.
［3］	Stephens MR, Putterman E, Yan AC, et al. Acquired port⁃wine stains in six pediatric patients［J］. Pediatr Dermatol, 2020,37（1）:93⁃97. doi: 10.1111/pde.14019.
［4］	Vural E, Ramakrishnan J, Cetin N, et al. The expression of vascular endothelial growth factor and its receptors in port⁃wine stains［J］. Otolaryngol Head Neck Surg, 2008,139（4）:560⁃564. doi: 10.1016/j.otohns.2008.07.015.
［5］	Lee KT, Park JE, Eom Y, et al. Phenotypic association of presence of a somatic GNAQ mutation with port⁃wine stain distribution in capillary malformation［J］. Head Neck, 2019,41（12）:4143⁃4150. doi: 10.1002/hed.25962.
［6］	Smoller BR, Rosen S. Port⁃wine stains. A disease of altered neural modulation of blood vessels?［J］. Arch Dermatol, 1986,122（2）:177⁃179. doi: 10.1001/archderm.122.2.177.
［7］	MacCormack MA. Photodynamic therapy［J］. Adv Dermatol, 2006,22:219⁃258. doi: 10.1016/j.yadr.2006.09.008.
［8］	Keller GS, Doiron D, Weingarten C. Advances in laser skin surgery for vascular lesions［J］. Arch Otolaryngol, 1985,111（7）:437⁃440. doi: 10.1001/archotol.1985.00800090051006.
［9］	Orenstein A, Nelson JS, Liaw LH, et al. Photochemotherapy of hypervascular dermal lesions: a possible alternative to photothermal therapy?［J］. Lasers Surg Med, 1990,10（4）:334⁃343. doi: 10.1002/lsm.1900100406.
［10］	顾瑛, 李峻亨, 郭中和，等. 光动力学疗法治疗鲜红斑痣［J］. 北京医学, 1991,13（5）:317.
［11］	Gu Y, Huang NY, Liang J, et al. Clinical study of 1949 cases of port wine stains treated with vascular photodynamic therapy （Gu's PDT）［J］. Ann Dermatol Venereol, 2007,134（3 Pt 1）:241⁃244. doi: 10.1016/s0151⁃9638（07）91816⁃5.
［12］	刘凡光, 顾瑛, 富秋涛, 等. 光动力疗法治疗鲜红斑痣的基础研究——血啉甲醚与血卟啉衍生物吸收特性的比较［J］. 中国激光医学杂志, 2001,10（1）:12⁃15. doi: 10.13480/j.issn1003⁃9430.2001.01.004.
［13］	Zhang B, Zhang TH, Huang Z, et al. Comparison of pulsed dye laser （PDL） and photodynamic therapy （PDT） for treatment of facial port⁃wine stain （PWS） birthmarks in pediatric patients［J］. Photodiagnosis Photodyn Ther, 2014,11（4）:491⁃497. doi: 10.1016/j.pdpdt.2014.06.004.
［14］	Gao K, Huang Z, Yuan KH, et al. Side⁃by⁃side comparison of photodynamic therapy and pulsed⁃dye laser treatment of port⁃wine stain birthmarks［J］. Br J Dermatol, 2013,168（5）:1040⁃1046. doi: 10.1111/bjd.12130.
［15］	Zhang M, Wu Q, Lin T, et al. Hematoporphyrin monomethyl ether photodynamic therapy for the treatment of facial port⁃wine stains resistant to pulsed dye laser［J］. Photodiagnosis Photodyn Ther, 2020,31:101820. doi: 10.1016/j.pdpdt.2020.101820.
［16］	Ebell MH, Siwek J, Weiss BD, et al. Strength of recommendation taxonomy （SORT）: a patient⁃centered approach to grading evidence in the medical literature［J］. J Am Board Fam Pract, 2004,17（1）:59⁃67. doi: 10.3122/jabfm.17.1.59.
［17］	Li X, Diao P, Liu L, et al. Hematoporphyrin monomethyl ether photodynamic therapy for the treatment of Sturge⁃Weber syndrome and large segmental facial port⁃wine stain［J］. Dermatol Ther, 2022,35（5）:e15404. doi: 10.1111/dth.15404.
［18］	Lyu J, Wang S, Li Y, et al. Hematoporphyrin monomethyl ether⁃mediated photodynamic therapy for phakomatosis pigmento⁃vascularis type Ⅱ: a case report［J］. Photodiagnosis Photodyn Ther, 2022,37:102637. doi: 10.1016/j.pdpdt.2021.102637.
［19］	Zhang Y, Wang D, Zhang L, et al. Hematoporphyrin monomethyl ether⁃mediated photodynamic therapy temporarily relieves severe pruritis from phakomatosis pigmentovascularis: a case report［J］. Photodiagnosis Photodyn Ther, 2021,33:102180. doi: 10.1016/j.pdpdt.2021.102180.
［20］	van Raath MI, Chohan S, Wolkerstorfer A, et al. Clinical outcome measures and scoring systems used in prospective studies of port wine stains: a systematic review［J］. PLoS One, 2020,15（7）:e0235657. doi: 10.1371/journal.pone.0235657.
［21］	van Raath MI, Chohan S, Wolkerstorfer A, et al. Port wine stain treatment outcomes have not improved over the past three decades［J］. J Eur Acad Dermatol Venereol, 2019,33（7）:1369⁃1377. doi: 10.1111/jdv.15599.
［22］	Zhao Y, Tu P, Zhou G, et al. Hemoporfin photodynamic therapy for port⁃wine stain: a randomized controlled trial［J］. PLoS One, 2016,11（5）:e0156219. doi: 10.1371/journal.pone.0156219.
［23］	Buch J, Karagaiah P, Raviprakash P, et al. Noninvasive diagnostic techniques of port wine stain［J］. J Cosmet Dermatol, 2021,20（7）:2006⁃2014. doi: 10.1111/jocd.14087.
［24］	Zhang H, Zhang G, Zhang Y, et al. Quantitatively assessing port⁃wine stains using a photoacoustic imaging method: a pilot study［J］. J Am Acad Dermatol, 2021,85（6）:1613⁃1616. doi: 10.1016/j.jaad.2020.12.024.
［25］	Li DC, Nong X, Hu ZY, et al. Efficacy and related factors analysis in HMME⁃PDT in the treatment of port wine stains［J］. Photodiagnosis Photodyn Ther, 2020,29:101649. doi: 10.1016/j.pdpdt.2020.101649.
［26］	Huang Y, Yang J, Sun L, et al. Efficacy of influential factors in hemoporfin⁃mediated photodynamic therapy for facial port⁃wine stains［J］. J Dermatol, 2021,48（11）:1700⁃1708. doi: 10.1111/1346⁃8138.16094.
［27］	Vázquez⁃López F, Coto⁃Segura P, Fueyo⁃Casado A, et al. Dermoscopy of port⁃wine stains［J］. Arch Dermatol, 2007,143（7）:962. doi: 10.1001/archderm.143.7.962.
［28］	Wang X, Suo H, Gao Y, et al. Correlation between the hemoporfin⁃mediated photodynamic treatment response and the dermoscopy vascular pattern in patients with a port⁃wine stain: a prospective study［J］. J Eur Acad Dermatol Venereol, 2020,34（12）:2795⁃2801. doi: 10.1111/jdv.16596.
［29］	Liu J, Zhou J, Hu D, et al. Retrospective analysis of hemoporfin⁃mediated photodynamic therapy in the treatment of naïve port⁃wine stains［J］. Photodiagnosis Photodyn Ther, 2022,39:103003. doi: 10.1016/j.pdpdt.2022.103003.
［30］	Tang Y, Xie H, Li J, et al. The association between treatment reactions and treatment efficiency of hemoporfin⁃photodynamic therapy on port wine stains: a prospective double blind randomized controlled trial［J］. Photodiagnosis Photodyn Ther, 2017,18:171⁃178. doi: 10.1016/j.pdpdt.2017.02.005.
［31］	Khalaf AT, Sun Y, Wang F, et al. Photodynamic therapy using hmme for port⁃wine stains: clinical effectiveness and sonographic appearance［J］. Biomed Res Int, 2020,2020:6030581. doi: 10. 1155/2020/6030581.
［32］	Zhang Y, Yang Y, Zhang Z, et al. Clinical study on hemoporfin PDT for infant facial port⁃wine stains［J］. Photodiagnosis Photodyn Ther, 2019,25:106⁃110. doi: 10.1016/j.pdpdt.2018.09. 012.
［33］	Xiao Q, Li Q, Yuan KH, et al. Photodynamic therapy of port⁃wine stains: long⁃term efficacy and complication in Chinese patients［J］. J Dermatol, 2011,38（12）:1146⁃1152. doi: 10.1111/j.1346⁃8138.2011.01292.x.
［34］	Yuan KH, Gao JH, Huang Z. Adverse effects associated with photodynamic therapy （PDT） of port⁃wine stain （PWS） birthmarks［J］. Photodiagnosis Photodyn Ther, 2012,9（4）:332⁃336. doi: 10.1016/j.pdpdt.2012.03.007.
［35］	Leff DR, Nortley M, Dang V, et al. The effect of local cooling on pain perception during infiltration of local anaesthetic agents, a prospective randomised controlled trial［J］. Anaesthesia, 2007,62（7）:677⁃682. doi: 10.1111/j.1365⁃2044.2007.05056.x.
［36］	Tyrrell J, Paterson C, Curnow A. Regression analysis of protoporphyrin ix measurements obtained during dermatological photodynamic therapy［J］. Cancers （Basel）, 2019,11（1）:72. doi: 10.3390/cancers11010072.
［37］	Yu W, Wang T, Zhu J, et al. EMLA cream does not influence efficacy and pain reduction during pulsed⁃dye laser treatment of port⁃wine stain: a prospective side⁃by⁃side comparison［J］. Lasers Med Sci, 2018,33（3）:573⁃579. doi: 10.1007/s10103⁃017⁃2415⁃3.
［38］	Langan SM, Collins P. Randomized, double⁃blind, placebo⁃controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2.5% and prilocaine 2.5% for topical 5⁃aminolaevulinic acid⁃photodynamic therapy for extensive scalp actinic keratoses［J］. Br J Dermatol, 2006,154（1）:146⁃149. doi: 10.1111/j.1365⁃2133.2005.06991.x.
［39］	Touma D, Yaar M, Whitehead S, et al. A trial of short incubation, broad⁃area photodynamic therapy for facial actinic keratoses and diffuse photodamage［J］. Arch Dermatol, 2004,140（1）:33⁃40. doi: 10.1001/archderm.140.1.33.
［40］	黄乃艳, 曾晶, 梁洁, 等. 泰勒宁缓解光动力治疗鲜红斑痣疼痛的临床观察［J］. 中国激光医学杂志, 2012,（5）:324.
［41］	周俊, 刘晶, 胡蝶, 等. 氟比洛芬酯在鲜红斑痣血卟啉单甲醚光动力疗法中镇痛效果的临床初步观察［J］. 中国皮肤性病学杂志, 2020,34（5）:534⁃537. doi: 10.13735/j.cjdv.1001⁃7089. 201908116.
［42］	Klein A, Karrer S, Horner C, et al. Comparing cold⁃air analgesia, systemically administered analgesia and scalp nerve blocks for pain management during photodynamic therapy for actinic keratosis of the scalp presenting as field cancerization: a randomized controlled trial［J］. Br J Dermatol, 2015,173（1）:192⁃200. doi: 10.1111/bjd.13547.
［43］	Lavand'homme P. Rebound pain after regional anesthesia in the ambulatory patient［J］. Curr Opin Anaesthesiol, 2018,31（6）:679⁃684. doi: 10.1097/ACO.0000000000000651.
［44］	Sinha C, Kumar A, Kumari P, et al. Does radial or median nerve blocks affect the area and blood flow of radial artery?［J］. Anaesth Crit Care Pain Med, 2021,40（2）:100831. doi: 10.1016/j.accpm.2021.100831.
［45］	鞠文, 李琪, 杨军, 等. 水合氯醛联合右美托咪定在小儿鲜红斑痣光动力治疗中的镇静作用［J］. 中国皮肤性病学杂志, 2022,36（2）:174⁃178. doi: 10.13735/j.cjdv.1001⁃7089.202104121.
［46］	王加芳, 李进, 汪云飞, 等. 艾司氯胺酮与舒芬太尼分别复合丙泊酚用于儿童鲜红斑痣光动力治疗麻醉效果的比较［J］. 实用医学杂志, 2023,39（1）:109⁃113. doi: 10.3969/j.issn.1006⁃5725.2023.01.019.
［47］	张智栋, 朱株材, 李崎, 等. 鲜红斑痣光动力治疗的疼痛管理策略［J］. 华西医学, 2023,38（2）:300⁃303.
［48］	顾瑛, 刘凡光, 王开, 等. 光动力疗法治疗鲜红斑痣1216例临床分析［J］. 中国激光医学杂志, 2001,10（2）:21⁃24. doi: 10. 13480/j.issn1003⁃9430.2001.02.008.
［49］	Gan LQ, Wang H, Ni SL, et al. A clinical study of HMME⁃PDT therapy in Chinese pediatric patients with port⁃wine stain［J］. Photodiagnosis Photodyn Ther, 2018,23:102⁃105. doi: 10.1016/j.pdpdt.2018.06.006.
［50］	Zhang LC, Yang J, Huang YB, et al. Efficacy of hemoporfin photodynamic therapy for pulsed dye laser⁃resistant facial port⁃wine stains in 107 children: a retrospective study［J］. Indian J Dermatol Venereol Leprol, 2022,88（2）:275. doi: 10.25259/IJDVL_976_20.
［51］	Han Y, Ying H, Zhang X, et al. Retrospective study of photodynamic therapy for pulsed dye laser⁃resistant port⁃wine stains［J］. J Dermatol, 2020,47（4）:348⁃355. doi: 10.1111/1346⁃8138.15238.
［52］	Wang S, Lee LY, Liu SX. Photodynamic therapy for port⁃wine stains in extremities: report of 4 cases［J］. Photodiagnosis Photodyn Ther, 2020,30:101781. doi: 10.1016/j.pdpdt.2020. 101781.
［53］	Liu L, Li E, Hao D, et al. A rare case of Klippel⁃Trenaunay syndrome in association with Sturge⁃Weber syndrome treated by HMME⁃PDT［J］. Photodermatol Photoimmunol Photomed, 2020,36（6）:490⁃492. doi: 10.1111/phpp.12587.
［54］	Zhang LC, Yang J, Huang YB, et al. Post treatment care in photodynamic therapy （PDT） of large facial port⁃wine stain （PWS） birthmarks［J］. Photodiagnosis Photodyn Ther, 2021,36:102604. doi: 10.1016/j.pdpdt.2021.102604.
［55］	Sommer S, Seukeran DC, Sheehan⁃Dare RA. Efficacy of pulsed dye laser treatment of port wine stain malformations of the lower limb［J］. Br J Dermatol, 2003,149（4）:770⁃775. doi: 10.1046/j.1365⁃2133.2003.05467.x.
［56］	Lin Y, Gong W, Kang J, et al. Hemoporfin⁃mediated photodynamic therapy for port⁃wine stains: multivariate analysis of clinical efficacy and optical coherence tomography appearance［J］. Front Med （Lausanne）, 2022,9:800836. doi: 10.3389/fmed.2022.800836.
［57］	Peng X, Ye T, Yu B, et al. Comparing HMME⁃PDT and Cynergy dual⁃wavelength laser in the treatment of facial PWS［J］. Photodiagnosis Photodyn Ther, 2022,37:102703. doi: 10.1016/j.pdpdt.2021.102703.
［58］	Zhang XY, Al⁃Odaini N, Fan RG, et al. The efficacy of hematoporphyrin monomethyl ether photodynamic therapy in adult patients with port⁃wine stains: a retrospective study［J］. Dermatol Ther （Heidelb）, 2022,12（4）:861⁃869. doi: 10.1007/s13555⁃022⁃00699⁃w.

[1]	Yang Aimin, Cheng Jiangwei, Huang Jiacheng, Cen Ying, Chen Junjie. Treatment of Merkel cell carcinoma [J]. Chinese Journal of Dermatology, 2024, 57(7): 665-667.
[2]	Liu Qingfeng, Liu Lian, Diao Ping, Li Xiaoxue, Zhang Ting, Chen Haotian, Liu Xu, Jiang Xian. Diagnosis and treatment of port-wine stains-associated syndromes [J]. Chinese Journal of Dermatology, 2024, 57(7): 656-660.
[3]	Chen Haotian, Liu Lian, Zhang Ting, Liu Qingfeng, Li Xiaoxue, Diao Ping, Jiang Xian. Port-wine stains: mechanisms underlying the development and progression [J]. Chinese Journal of Dermatology, 2024, 57(7): 661-664.
[4]	Diao Ping, Han Chenglong, Liu Lian, Zhou Hui, Li Erlong, Jiang Xian. Efficacy and influencing factors of hematoporphyrin monomethyl ether-mediated photodynamic therapy in the treatment of adult patients with port-wine stains: a retrospective study [J]. Chinese Journal of Dermatology, 2024, 57(7): 595-600.
[5]	Zhang Ting, Liu Lian, Chen Haotian, Wei Danfeng, Liu Xu, Diao Ping, Liu Qingfeng, Jiang Xian. Efficacy of 595-nm pulsed dye laser in the treatment of port‐wine stains in 155 infants and toddlers: a retrospective analysis [J]. Chinese Journal of Dermatology, 2024, 57(7): 610-615.
[6]	Zhang Sheng, Wang Xiuwei, Chen Jianyou, Deng Wei, Zhang Haihua, Zhang Gaolei, Liu Xiaoyan, Su Wei. Efficacy of hematoporphyrin monomethyl ether-mediated photodynamic therapy in the treatment of facial port-wine stains in 15 children with Sturge-Weber syndrome [J]. Chinese Journal of Dermatology, 2024, 57(7): 616-622.
[7]	Jiang Xian, Liu Lian, Zhang Ting. Treatment of port-wine stains: current status and prospects [J]. Chinese Journal of Dermatology, 2024, 57(7): 590-594.
[8]	Chinese Society of Dermatology, Dermatology and Venereology Branch of Chinese Association of Rehabilitation Medicine, China Dermatologist Association. Expert consensus on the clinical application of allergen-specific IgE tests in atopic dermatitis （2024 edition） [J]. Chinese Journal of Dermatology, 2024, 57(6): 493-502.
[9]	Sui Changlin, Chang Xiao, Zhao Qi, Zhu Wei. Psoriasis induced by anti-tumor targeted therapy and immunotherapy [J]. Chinese Journal of Dermatology, 2024, 57(6): 570-574.
[10]	Wang Chen, Xue Chenhong, Song Jinghui, Li Jianguo, Li Zhenlu, Zhang Shoumin, Li Ming, Wang Jianbo. Adalimumab for the treatment of three cases of Blau syndrome in a pedigree [J]. Chinese Journal of Dermatology, 2024, 57(6): 553-556.
[11]	Writing Committee Expert Group on “Treatment of Extramammary Paget′s Disease: a Chinese Expert Consensus Statement （）”. Treatment of extramammary Paget′s disease: a Chinese expert consensus statement （2024） [J]. Chinese Journal of Dermatology, 2024, 57(5): 400-408.
[12]	Mycobacteriosis Research Group, China “Belt and Road” Dermatology Alliance, Division of Dermatology and STI Diagnosis, Chinese Association on Leprosy. Expert consensus on the clinical diagnosis and treatment of cutaneous tuberculosis in China （2024） [J]. Chinese Journal of Dermatology, 2024, 57(5): 426-434.
[13]	China Dermatologist Association, Combination of Traditional and Western Medicine Dermatology. Diagnosis and treatment of erythrodermic psoriasis: a Chinese expert consensus statement （2024） [J]. Chinese Journal of Dermatology, 2024, 57(5): 409-417.
[14]	Chinese Society of Dermatology, China Dermatologist Association, Chinese Association of Integrative Medicine Board of Dermatovenereology. Expert consensus on the clinical application of chemical peeling in China （2024 public version） [J]. Chinese Journal of Dermatology, 2024, 0(5): 20230620-e20230620.
[15]	Yue Shuzhen, Shu Ye, Luo Yangyang, Li Keyao, Zhang Yuanyuan, Tang Jianping, Wei Zhu. Efficacy and safety of omalizumab in the treatment of chronic urticaria in children: a retrospective study [J]. Chinese Journal of Dermatology, 2024, 57(4): 354-358.

Expert consensus on hematoporphyrin monomethyl ether-mediated photodynamic therapy for treating port-wine stains （2024）

PDF

Knowledge

Abstract

Cite this article

share this article

References ［58］

Related Articles 15

Metrics

Comments

Recommended 10